Find the right fit for you - faster
Get tailored insights about working at Immunai in one quick step.
Immunai Snapshot
Founded in December 2018, Immunai is on a mission to revolutionize drug discovery and development.
Immunai is an engineering-first platform company aiming to improve therapeutic decision-making throughout the drug discovery and development process. We are mapping the immune system at unprecedented scale and granularity and applying machine learning to this massive clinico-immune database, in order to generate novel insights into disease pathology for our partners - pharma companies and research institutes. We provide a comprehensive, end-to-end solution - from data generation and curation to therapeutics development, that continuously supports and validates the capabilities of our platform.
As drug development is becoming increasingly inefficient, our ultimate goal is to help bring breakthrough medicines to patients as quickly and successfully as possible.
With a global presence spanning New York City, Tel Aviv, Prague, and Zurich, our multidisciplinary team is dedicated to advancing innovation in drug discovery and development, bringing breakthrough therapies to patients worldwide.
As drug development is becoming increasingly inefficient, our ultimate goal is to help bring breakthrough medicines to patients as quickly and successfully as possible.
With a global presence spanning New York City, Tel Aviv, Prague, and Zurich, our multidisciplinary team is dedicated to advancing innovation in drug discovery and development, bringing breakthrough therapies to patients worldwide.
